5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 17905496 | PHARMACEUTICAL FORMULATION COMPRISING BEVACIZUMAB | SAOUD, CHRISTINE J | 1645 | Non-Final OA | Sep 01, 2022 |
| 17822710 | ANTI-CD137 CONSTRUCTS AND USES THEREOF | SANG, HONG | 1646 | Non-Final OA | Aug 26, 2022 |
| 17822737 | ANTI-CD137 CONSTRUCTS, MULTISPECIFIC ANTIBODY AND USES THEREOF | BRISTOL, LYNN ANNE | 1643 | Final Rejection | Aug 26, 2022 |
| 17811455 | ANTI-TIGIT ANTIBODIES AND METHODS OF USE | HOPKINS, SAMANTHA LAKE | 1641 | Non-Final OA | Jul 08, 2022 |
| 17758399 | PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE THEREOF | CHEONG, CHEOM-GIL | 1645 | Final Rejection | Jul 05, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial